Robert Baffi, EVP, Technical Operations at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 19,575 shares at $55.00 ($1.1M) on 2013-01-22, disclosed to the SEC on 2013-01-23.
Scheduled sale ($1.1M) by EVP, Technical Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BMRN | SELL | 2017-10-02 | $2.0M | — | Filing → |
| BMRN | SELL | 2016-05-19 | $435K | — | Filing → |
| BMRN | SELL | 2015-03-05 | $1.6M | — | Filing → |